Point: Short-Course Radiation Therapy Is Preferable in the Neoadjuvant Treatment of Rectal Cancer

Seminars in Radiation Oncology

Volumn 21, Issue 3, 2011, Pages 220-227

  Bujko, Krzysztof ^a   Bujko, Magdalena ^a  

^a INSTITUTE OF ONCOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CAPECITABINE; FLUOROURACIL; FOLINIC ACID; OXALIPLATIN;

ACUTE TOXICITY; AUSTRALIA; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CHEMORADIOTHERAPY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; GASTROINTESTINAL SYMPTOM; HUMAN; INTERMETHOD COMPARISON; MORTALITY; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PARESTHESIA; POLAND; PREOPERATIVE RADIOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; REVIEW; RISK FACTOR; SEXUAL DYSFUNCTION; SHORT COURSE THERAPY; WEAKNESS;

CHEMOTHERAPY, ADJUVANT; DOSE FRACTIONATION; EVIDENCE-BASED MEDICINE; HUMANS; LYMPHATIC METASTASIS; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREOPERATIVE CARE; RADIOTHERAPY DOSAGE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECTAL NEOPLASMS; SURVIVAL RATE; TIME FACTORS;

EID: 79958001470     PISSN: 10534296     EISSN: 15329461     Source Type: Journal    
DOI: 10.1016/j.semradonc.2011.02.008     Document Type: Review

References (43)

1. Frykholm G.J., Glimelius B., Pahlman L. Preoperative or postoperative irradiation in adenocarcinoma of the rectum: Final treatment results of a randomized trial and evaluation of late secondary effects. Dis Colon Rectum 1993, 36:564-572.
2. Sauer R., Becker H., Hohenberger W., et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004, 351:1731-1740.
3. Francois Y., Nemoz C.J., Bauliex J. Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial. J Clin Oncol 1999, 17:2396-2402.
4. Suit H.D., Gallager H.S. Intact tumor cells in irradiated tissue. Arch Pathol 1964, 78:648-651.
5. Nagtegaal I.D., Marijnen C.A., Kranenbarg E.K., et al. Short-term preoperative radiotherapy interferes with the determination of pathological parameters in rectal cancer. J Pathol 2002, 197:20-27.
6. Marijnen C.A., Nagtegaal I.D., Klein-Kranenbarg E., et al. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 2001, 19:1976-1984.
7. Yeo S.G., Kim D.Y., Kim T.H. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 2010, 78:164-171.
8. Bosset J.F., Collette L., Calais G., et al. Chemoradiotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006, 355:1114-1123.
9. Braendengen M., Tveit K.M., Berglund A., et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008, 26:3687-3694.
10. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Sphincter preservation following preoperative radiotherapy for rectal cancer: Report of a randomized trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother Oncol 2004, 72:15-24.
11. Gerard J.P., Conroy T., Bonnetain F., et al. Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: Results of FFCD 9203. J Clin Oncol 2006, 24:4620-4625.
12. Bujko K., Nowacki M.P., Nasierowska-Guttmejer A., et al. Long-term results of randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 2006, 93:1215-1223.
13. Pietrzak L., Bujko K., Nowacki M.P., et al. Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: Report of a randomised trial. Radiother Oncol 2007, 84:217-225.
14. Bujko K., Nowacki M.P., Kepka L., et al. Postoperative complications in patients irradiated pre-operatively for rectal cancer: Report of a randomised trial comparing short-term radiotherapy vs chemoradiation. Colorectal Dis 2005, 7:410-416.
15. Ngan S., Fisher R., Goldstein D. A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: An intergroup trial (TROG, AGITG, CSSANZ, RACS). J Clin Oncol 2010, 28:15s. (suppl, abstr :3509).
16. Ngan S., Fisher R., Mackay J. Acute adverse events in a randomised trial of short course versus long course preoperative radiotherapy for T3 adenocarcinoma of rectum: A Trans-Tasman Radiation Oncology Group trial (TROG 01.04). Eur J Cancer 2007, 4:237. (suppl 5, abstr).
17. Folkesson J., Birgisson H., Pahlman L., et al. Swedish Rectal Cancer Trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J Clin Oncol 2005, 23:5644-5650.
18. Martling A.L., Holm T., Johansson H., et al. The Stockholm II trial on preoperative radiotherapy in rectal carcinoma. Long-term follow-up of a population-based study. Cancer 2001, 92:896-902.
19. Peeters K.C., Marijnen C.A., Nagtegaal I.D., et al. The TME trial after a median follow-up of 6 years: Increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007, 246:693-701.
20. Pettersson D., Cedermark B., Holm T., et al. Interim analysis of the Stockholm III trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg 2010, 97:580-587.
21. Sebag-Montefiore D., Stephens R.J., Steele R., et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): A multicentre, randomised trial. Lancet 2009, 373:811-820.
22. Preoperative short-term radiation therapy in operable rectal carcinoma. A prospective randomized trial. Cancer 1990, 66:49-55. Stockholm Colorectal Cancer Study Group.
23. Kapiteijn E., Marijnen C.A.M., Nagtegaal I.D., et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001, 345:638-646.
24. Marijnen C.A., Kapiteijn E., van de Velde C.J., et al. Acute side effects and complications after short-term preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: Report of a multicenter randomized trial. J Clin Oncol 2002, 20:817-825.
25. Roh M.S., Colangelo L.H., O'Connell M.J., et al. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 2009, 27:5124-5130.
26. Cionini L., Manfredi B., Sainato A. Randomized study of postoperative chemotherapy (CT) after preoperative chemoradiation (CTRT) in locally advanced rectal cancer (LARC). Preliminary results. Eur J Cancer 2001, 37:S300. (abstr).
27. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 1997, 336:980-987. Swedish Rectal Cancer Trial.
28. Birgisson H., Pahlman L., Gunnarsson U., et al. Adverse effects of preoperative radiation therapy for rectal cancer: Long-term follow-up of the Swedish Rectal Cancer Trial. J Clin Oncol 2005, 23:8697-8705.
29. Bujko K., Kolodziejczyk M. The 5x5Gy with delayed surgery in non-resectable rectal cancer: A new treatment option. Radiother Oncol 2008, 87:311-313.
30. Peeters K.C.M.J., van de Velde C.J., Leer J.W.H., et al. Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: Increased bowel dysfunction in irradiated patients-A Dutch Colorectal Cancer Group Study. J Clin Oncol 2005, 23:6199-6206.
31. Marijnen C.A.M., van de Velde C.J., Putter H., et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: Report of multicenter randomized trial. J Clin Oncol 2005, 23:1847-1858.
32. Holm T., Singnomklao T., Rutqvist L.E., et al. Adjuvant preoperative radiotherapy in patients with rectal carcinoma. Adverse effects during long term follow-up in two randomised trials. Cancer 1996, 78:968-976.
33. Frykholm J.G., Sintorn K., Montelius A., et al. Acute lumbosacral plexopathy during and after preoperative radiotherapy of rectal adenocarcinoma. Radiother Oncol 1996, 38:121-130.
34. Marijnen C.A., Nagtegaal I.D., Kapiteijn E., et al. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: Report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003, 55:1311-1320.
35. Mohiuddin M., Marks J., Marks G. Management of rectal cancer: Short-vs. long-course preoperative radiation. Int J Radiat Oncol Biol Phys 2008, 72:636-643.
36. Bujko K., Kepka L., Michalski W., et al. Does rectal cancer shrinkage induced by preoperative radio(chemo)therapy increase the likelihood of anterior resection?. A systematic review of randomised trials. Radiother Oncol 2006, 80:4-12.
37. Wong R.K.S., Tandan V., De Silva S. Pre-operative radiotherapy and curative surgery for the management of localized rectal carcinoma. Cochrane Database Syst Rev 2007, 2. CD002102.
38. Bujko K., Richter P., Kołodziejczyk M., et al. Preoperative radiotherapy and local excision of rectal cancer with immediate radical re-operation for poor responders. Radiother Oncol 2009, 92:195-201.
39. Radu C., Berglund A., Pahlman L., et al. Short course preoperative radiotherapy with delayed surgery in rectal cancer-A retrospective study. Radiother Oncol 2008, 87:343-349.
40. Hatfield P., Hingorani M., Radhakrishna G., et al. Short-course radiotherapy, with elective delay prior to surgery, in patients with unresectable rectal cancer who have poor performance status or significant co-morbidity. Radiother Oncol 2009, 92:210-214.
41. Van Dijk T.H., Hospers G.A.P., Beukema J.C. Short-course radiation therapy, neoadjuvant bevacizumab, capecitabine and oxaliplatin, and radical resection of primary tumour and metastases in primary stage IV rectal cancer: A phase II multicenter study of the Dutch colorectal cancer Group. Ann Oncol 2010, 21:i51. (suppl 1, abstr).
42. Gasinska A., Skolyszewski J., Popiela T., et al. Bromodeoxyuridine labeling index as an indicator of early tumor response to preoperative radiotherapy in patients with rectal cancer. J Gastrointest Surg 2007, 11:520-528.
43. Lievens Y., Van den Bogaert W., Rijnders A., et al. Palliative radiotherapy practice within Western European countries: Impact of the radiotherapy financing system?. Radiother Oncol 2000, 56:289-295.